JP MORGAN/CALL/LEIDOS/145/0.1/20.12.24 Share Price

Warrant

DE000JK8GS74

Market Closed - Börse Stuttgart 01:19:05 07/06/2024 pm IST
1.51 EUR -6.21% Intraday chart for JP MORGAN/CALL/LEIDOS/145/0.1/20.12.24
Current month-6.21%
1 month-3.21%
Date Price Change
07/24/07 1.51 -6.21%
06/24/06 1.61 +3.21%
05/24/05 1.56 -3.11%
04/24/04 1.61 -8.52%
03/24/03 1.76 +9.32%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 01:19 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying LEIDOS HOLDINGS, INC.
Issuer J.P. Morgan
WKN JK8GS7
ISINDE000JK8GS74
Date issued 02/05/2024
Strike 145 $
Maturity 20/12/2024 (195 Days)
Parity 10 : 1
Emission price 0.7
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.07
Lowest since issue 1.51
Delta0.58x
Omega 4.820
Premium12.15x
Gearing8.3x
Moneyness 0.9990
Difference Strike 0.15 $
Difference Strike %+0.10%
Spread 0.09
Spread %5.42%
Theoretical value 1.615
Implied Volatility 38.40 %
Total Loss Probability 52.64 %
Intrinsic value 0.000000
Present value 1.615
Break even 162.45 €
Theta-0.03x
Vega0.04x
Rho0.03x

Company Profile

Leidos Holdings, Inc. specializes in the provision of engineering, technological and scientific services. Net sales by business segment break down as follows: - defense (56.6%): design, engineering and integration of technological solutions for intelligence, airborne surveillance and reconnaissance, maritime and land-based solutions, electronic warfare systems, and automated sensor, alarm, command and control systems, software development, cyber security solutions and data processing and analysis solutions, IT infrastructure development and integration, etc.; - civil security (23.7%): development and integration of solutions for the protection of goods, data and digital information, solutions and systems for air traffic flow control and flight data management, vehicle and cargo inspection, explosives and radiation detection, computer security, environmental management, nuclear security, complex logistics management, etc.; - health (19.7%): integration of complex systems and technological infrastructures for the management of data, medical information and electronic health records, provision of healthcare services, IT systems lifecycle management, research and development of biopharmaceuticals, etc. Net sales by market are divided between the US Department of Defense and the intelligence community (49.4%), government agencies (37.4%) and commercial customers (13.2%). The United States accounts for 91,4% of net sales.
Sector
-
More about the company

Ratings for Leidos Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Leidos Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
144.8 USD
Average target price
159.2 USD
Spread / Average Target
+9.89%
Consensus